BMC Medical Co., Ltd.

SZSE:301367 Stock Report

Market Cap: CN¥5.6b

BMC Medical Future Growth

Future criteria checks 4/6

BMC Medical is forecast to grow earnings and revenue by 23.8% and 23.2% per annum respectively. EPS is expected to grow by 23.2% per annum. Return on equity is forecast to be 16% in 3 years.

Key information

23.8%

Earnings growth rate

23.2%

EPS growth rate

Medical Equipment earnings growth23.1%
Revenue growth rate23.2%
Future return on equity16.0%
Analyst coverage

Low

Last updated25 Mar 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

SZSE:301367 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20252,236636N/A5961
12/31/20241,784500N/A4691
12/31/20231,427396N/A3591
9/30/20231,346381250276N/A
6/30/20231,599471292321N/A
3/31/20231,689483383410N/A
12/31/20221,415380351375N/A
9/30/20221,223297241259N/A
1/1/202266314694104N/A
12/31/2020560228252267N/A
12/31/2019258393136N/A
12/31/2018189251821N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 301367's forecast earnings growth (23.8% per year) is above the savings rate (2.9%).

Earnings vs Market: 301367's earnings (23.8% per year) are forecast to grow slower than the CN market (26.4% per year).

High Growth Earnings: 301367's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 301367's revenue (23.2% per year) is forecast to grow faster than the CN market (15.2% per year).

High Growth Revenue: 301367's revenue (23.2% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 301367's Return on Equity is forecast to be low in 3 years time (16%).


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.